Hematological Changes in Liver Disease

Introduction to Liver Disease Indicators

The American Association for the Study of Liver Diseases recommends that thrombocytopenia, a low platelet count, is the most common hematological abnormality in chronic liver disease, serving as an indicator of advanced disease rather than elevated counts 1, 2
The European Association for the Study of the Liver states that decreased production from bone marrow suppression, splenic sequestration from portal hypertension, and increased destruction from shear stress, fibrinolysis, and bacterial translocation are mechanisms contributing to thrombocytopenia in liver disease 1, 2

The National Institute of Diabetes and Digestive and Kidney Diseases suggests that the appropriate initial investigation for potential liver disease includes bilirubin, albumin, ALT, ALP, and GGT, together with a full blood count 3, 4
The American College of Gastroenterology recommends that the pattern of abnormality in liver function tests, such as hepatocellular or cholestatic patterns, matters more than isolated cell counts in indicating liver problems 5

The American Association for the Study of Liver Diseases indicates that when liver disease progresses to cirrhosis, expect decreased blood counts, not elevated ones, due to mechanisms such as hypersplenism and multiple anemia mechanisms 1, 2

The American Association for the Study of Liver Diseases recommends that liver function tests, including bilirubin, albumin, ALT, ALP, GGT, and a complete blood count, should be used for initial investigation, rather than isolated WBC/RBC interpretation, as liver function tests used in isolation are neither specific diagnostic tools nor effective exclusion tools, with only 3.9% of patients with abnormal ALT/AST being diagnosed with significant liver disease within 5 years 6

Elevated WBC counts, particularly with C-reactive protein ≥50 mg/L, may suggest infected hepatic cysts in polycystic liver disease, with WBC > normal being a strong indicator of acute liver cyst infection 7
Coagulation activation markers, such as those reflecting consumptive coagulopathy, may be considered in advanced disease, though these are not simple blood count elevations, and are associated with advanced liver disease 8, 9